149 related articles for article (PubMed ID: 32185277)
21. Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
Kohlmann R; Salmen A; Chan A; Knabbe C; Diekmann J; Brockmeyer N; Skaletz-Rorowski A; Michalik C; Gold R; Überla K
Mult Scler; 2015 Dec; 21(14):1823-32. PubMed ID: 25828755
[TBL] [Abstract][Full Text] [Related]
22. Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list.
Speth F; Hinze CH; Andel S; Mertens T; Haas JP
Pediatr Rheumatol Online J; 2018 Mar; 16(1):15. PubMed ID: 29499726
[TBL] [Abstract][Full Text] [Related]
23. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis.
Sepriano A; Kerschbaumer A; Smolen JS; van der Heijde D; Dougados M; van Vollenhoven R; McInnes IB; Bijlsma JW; Burmester GR; de Wit M; Falzon L; Landewé R
Ann Rheum Dis; 2020 Jun; 79(6):760-770. PubMed ID: 32033941
[TBL] [Abstract][Full Text] [Related]
24. Tofacitinib modulates the VZV-specific CD4+ T cell immune response in vitro in lymphocytes of patients with rheumatoid arthritis.
Almanzar G; Kienle F; Schmalzing M; Maas A; Tony HP; Prelog M
Rheumatology (Oxford); 2019 Nov; 58(11):2051-2060. PubMed ID: 31106368
[TBL] [Abstract][Full Text] [Related]
25. Risk of herpes/herpes zoster during anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Systematic review and meta-analysis.
Che H; Lukas C; Morel J; Combe B
Joint Bone Spine; 2014 May; 81(3):215-21. PubMed ID: 23932722
[TBL] [Abstract][Full Text] [Related]
26. VZV T cell-mediated immunity.
Weinberg A; Levin MJ
Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
[TBL] [Abstract][Full Text] [Related]
27. Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis.
Curtis JR; Xie F; Yun H; Bernatsky S; Winthrop KL
Ann Rheum Dis; 2016 Oct; 75(10):1843-7. PubMed ID: 27113415
[TBL] [Abstract][Full Text] [Related]
28. No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database.
Sakai R; Kasai S; Hirano F; Harada S; Kihara M; Yokoyama W; Tsutsumino M; Nagasaka K; Koike R; Yamanaka H; Miyasaka N; Harigai M
Int J Rheum Dis; 2018 Sep; 21(9):1670-1677. PubMed ID: 29667330
[TBL] [Abstract][Full Text] [Related]
29. Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults.
Levin MJ; Schmader KE; Pang L; Williams-Diaz A; Zerbe G; Canniff J; Johnson MJ; Caldas Y; Cho A; Lang N; Su SC; Parrino J; Popmihajlov Z; Weinberg A
J Infect Dis; 2016 Jan; 213(1):14-22. PubMed ID: 26452397
[TBL] [Abstract][Full Text] [Related]
30. Herpes zoster after lung transplantation boosts varicella zoster virus-specific adaptive immune responses.
van Besouw NM; van Hal PT; Zuijderwijk JM; de Kuiper R; Hoek RA; van Weezel JJ; van der Eijk AA; Verjans GM; Weimar W
J Heart Lung Transplant; 2016 Dec; 35(12):1435-1442. PubMed ID: 27293105
[TBL] [Abstract][Full Text] [Related]
31. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection.
Schub D; Janssen E; Leyking S; Sester U; Assmann G; Hennes P; Smola S; Vogt T; Rohrer T; Sester M; Schmidt T
J Infect Dis; 2015 Feb; 211(4):600-12. PubMed ID: 25180236
[TBL] [Abstract][Full Text] [Related]
32. The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation.
Whitmer T; Malouli D; Uebelhoer LS; DeFilippis VR; Früh K; Verweij MC
J Virol; 2015 Sep; 89(17):8687-700. PubMed ID: 26085158
[TBL] [Abstract][Full Text] [Related]
33. Relationship between cell-mediated immunity to Varicella-Zoster virus and aging in subjects from the community-based Shozu Herpes Zoster study.
Shirane R; Tang H; Hayashi K; Okuno Y; Iso H; Asada H; Yamanishi K; Mori Y;
J Med Virol; 2017 Feb; 89(2):313-317. PubMed ID: 27420414
[TBL] [Abstract][Full Text] [Related]
34. The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity.
Weinberg A; Pang L; Johnson MJ; Caldas Y; Cho A; Tovar-Salazar A; Canniff J; Schmader KE; Popmihajlov Z; Levin MJ
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092579
[TBL] [Abstract][Full Text] [Related]
35. Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases.
Rondaan C; de Haan A; Horst G; Hempel JC; van Leer C; Bos NA; van Assen S; Bijl M; Westra J
Arthritis Rheumatol; 2014 Nov; 66(11):3122-8. PubMed ID: 25223407
[TBL] [Abstract][Full Text] [Related]
36. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial.
Trannoy E; Berger R; Holländer G; Bailleux F; Heimendinger P; Vuillier D; Creusvaux H
Vaccine; 2000 Feb; 18(16):1700-6. PubMed ID: 10689152
[TBL] [Abstract][Full Text] [Related]
37. The frequency of varicella-zoster virus infection in patients with multiple sclerosis receiving fingolimod.
Aramideh Khouy R; Karampoor S; Keyvani H; Bokharaei-Salim F; Monavari SH; Taghinezhad S; Etemadifar M; Esghaei M
J Neuroimmunol; 2019 Mar; 328():94-97. PubMed ID: 30610966
[TBL] [Abstract][Full Text] [Related]
38. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.
Wilson A; Sharp M; Koropchak CM; Ting SF; Arvin AM
J Infect Dis; 1992 Jan; 165(1):119-26. PubMed ID: 1309369
[TBL] [Abstract][Full Text] [Related]
39. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial.
Mullane KM; Morrison VA; Camacho LH; Arvin A; McNeil SA; Durrand J; Campbell B; Su SC; Chan ISF; Parrino J; Kaplan SS; Popmihajlov Z; Annunziato PW;
Lancet Infect Dis; 2019 Sep; 19(9):1001-1012. PubMed ID: 31399378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
